In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abbott, Triangle co-promote antiviral products

Executive Summary

In its attempt to become the leading HIV healthcare company, Abbott Laboratories has entered into a $335mm deal with Triangle Pharmaceuticals, in which the two will co-promote six antiviral drugs--four of Triangle's HIV and hepatitis B (HBV) products, and two of Abbott's HIV protease inhibitors.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Co-Promotion
    • Includes Equity
    • Includes Royalty or Profit Split Information
    • Manufacturing or Supply
    • R&D and Marketing (Licensing)
    • Reverse Licensing

Related Companies